Every two years, doctors specialising in breast cancer gather in St Gallen to discuss developments and update guidelines on adjuvant therapies. It is always an important conference, but its conclusions tend to be measured rather than headline grabbing.
Related Articles
Cover Story
Emiel Rutgers: a surgeon for the genomic era
Impact Factor
Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?
Senza categoria